当前位置: 首页 > 期刊 > 《新医学》 > 201912
编号:13524381
心房颤动心房肌β3-肾上腺素能受体通过NADPH氧化酶产生氧化应激研究(5)
http://www.100md.com 2019年12月1日 《新医学》 201912
     [13] Li X, Yang X, Li Y, Yuan M, Tian C, Yang Y, Zhang X, Liu C, Gao Y, Liu N, Shang H, Xing Y. Mitochondria and the pathophysiological mechanism of atrial fibrillation. Curr Pharm Des, 2018,24(26):3055-3061.

    [14] Barangi S, Hayes AW, Karimi G. The more effective treatment of atrial fibrillation applying the natural compounds; as NADPH oxidase and ion channel inhibitors. Crit Rev Food Sci Nutr, 2018,58(7):1230-1241.

    [15] Barr LA, Lambert JP, Shimizu Y, Barouch LA, Naqvi N, Calvert JW. Exercise training provides cardioprotection by activating and coupling endothelial nitric oxide synthase via a β3-adrenergic receptor-AMP-activated protein kinase signaling pathway. Med Gas Res,2017,7(1):1-8.

    [16] Schena G, Caplan MJ. Everything you always wanted to know about β3-AR * (* but were afraid to ask).Cells,2019,8(4). pii: E357.

    [17] 郭海燕, 楊静, 富路. 抑制NADPH氧化酶对心血管疾病保护作用研究进展.中华实用诊断与治疗杂志,2016,30(10):953-955.

    [18] 张梓桑, 张薪茹, 张庄, 李光宇,张劲松,杜荣增. 心房颤动患者外周血淋巴细胞β3肾上腺素受体的表达水平及临床意义.中国循环杂志,2019,34(4):363-369.

    (收稿日期:2019-06-19)

    (本文编辑:杨江瑜), http://www.100md.com(张苗苗?李为民?董晶妹)
上一页1 2 3 4 5